Skip to main content
Carl Allen, MD, Pediatric Hematology & Oncology, Houston, TX, Texas Children's Hospital

CarlEAllenMD

Pediatric Hematology & Oncology Houston, TX

Professor, Pediatric Hematology & Oncology, Baylor College of Medicine

Dr. Allen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Allen's full profile

Already have an account?

Education & Training

  • Baylor College of Medicine
    Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2005 - 2008
  • Nationwide Children's Hospital/Ohio State University
    Nationwide Children's Hospital/Ohio State UniversityResidency, Pediatrics, 2002 - 2005
  • Ohio State University College of Medicine
    Ohio State University College of MedicineClass of 2002

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2008 - 2025
  • OH State Medical License
    OH State Medical License 2003 - 2005
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Case Report: Secondary Hemophagocytic Lymphohistiocytosis with Disseminated Infection in Chronic Granulomatous Disease—A Serious Cause of Mortality  
    Caridad A Martinez, Carl E Allen, Prakash Satwani, Frontiers in Immunology
  • Reduced Intensity Conditioning for Hematopoietic Cell Transplant for HLH and Primary Immune Deficiencies: BMT CTN 1204  
    Shalini Shenoy, K Scott Baker, Elizabeth O Stenger, Mary Eapen, Carl Allen, Lauri Burroughs, Philip Roehrs, Catherine M Bollard, Rabi Hanna, Jeffrey R Andolina, James ..., Blood

Abstracts/Posters

  • Genomic Characterization of a Pediatric Cohort with Non-Malignant Lymphoproliferative Disorders
    Carl E. Allen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • TCR Repertoire Clonality Analysis and Transcriptome Analyses of Immune Infiltrates in Patients with Langerhans Cell Histiocytosis Can Define Prognostic Biomarkers for ...
    Carl E. Allen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Blocking MAPK Activation and Immune Checkpoints Reverse Immune Dysfunction and Reduce Disease in a Mouse Model of LCH
    Carl E. Allen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Press Mentions

  • NCI-COG Pediatric MATCH Study Shows Benefit of Genetic Screening in Refractory Tumors
    NCI-COG Pediatric MATCH Study Shows Benefit of Genetic Screening in Refractory TumorsApril 4th, 2022
  • Selumetinib Shows ‘Limited Efficacy’ for Paediatric Tumours with MAPK Pathway Alterations
    Selumetinib Shows ‘Limited Efficacy’ for Paediatric Tumours with MAPK Pathway AlterationsFebruary 6th, 2022
  • Researchers Identify Cause and Drug Targets for Bewildering Rare Children's Disease
    Researchers Identify Cause and Drug Targets for Bewildering Rare Children's DiseaseMay 6th, 2021
  • Join now to see all

Hospital Affiliations